Literature DB >> 15034208

Autocrine stimulation in colorectal carcinoma (CRC): positive autocrine loops in human colorectal carcinoma and applicable significance of blocking the loops.

Wen-Jing Ruan1, Mao-De Lai.   

Abstract

Many tumors co-express growth factors and their receptors; thus, the concept of autocrine secretion was proposed to explain the unrestrained growth of the malignant cells. Autocrine stimulation refers to positive autocrine secretion, which functions to stimulate cell growth. Many of the positive autocrine loops have been demonstrated in human colorectal carcinoma (CRC), which are considered to play an important role in the initiation and progression of the cancer. These autocrine loops provide information for prognostic markers and targets for biological therapies of CRC. Interruption of the autocrine loops could potentially inhibit malignant cell growth. The field is encouraging but further research is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034208     DOI: 10.1385/MO:21:1:01

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  28 in total

1.  Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop.

Authors:  Robert Ducroc; Claire Bontemps; Katia Marazova; Hélène Devaud; Dalila Darmoul; Marc Laburthe
Journal:  Life Sci       Date:  2002-02-08       Impact factor: 5.037

2.  Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel.

Authors:  Chiara Barozzi; Matteo Ravaioli; Antonia D'Errico; Gian Luca Grazi; Gilberto Poggioli; Giulia Cavrini; Alighieri Mazziotti; Walter Franco Grigioni
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

3.  IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line.

Authors:  T Lamonerie; C Lavialle; H Haddada; O Brison
Journal:  Int J Cancer       Date:  1995-05-16       Impact factor: 7.396

4.  Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide.

Authors:  N M Hoosein; P A Kiener; R C Curry; M G Brattain
Journal:  Exp Cell Res       Date:  1990-01       Impact factor: 3.905

5.  Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene.

Authors:  S A Huang; P F Lin; D Fan; J E Price; J M Trujillo; S Chakrabarty
Journal:  J Cell Physiol       Date:  1991-08       Impact factor: 6.384

6.  Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states.

Authors:  D Jiang; H Yang; J K Willson; J Liang; L E Humphrey; E Zborowska; D Wang; J Foster; R Fan; M G Brattain
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

7.  Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.

Authors:  S Baghdiguian; B Verrier; C Gerard; J Fantini
Journal:  Cancer Lett       Date:  1992-02-14       Impact factor: 8.679

8.  Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells.

Authors:  H Lahm; P Amstad; A Yilmaz; Z Borbenyi; J Wyniger; J R Fischer; L Suardet; J C Givel; N Odartchenko
Journal:  Cell Growth Differ       Date:  1995-09

9.  Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.

Authors:  G R Johnson; T Saeki; A W Gordon; M Shoyab; D S Salomon; K Stromberg
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

10.  Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.

Authors:  D Darmoul; J C Marie; H Devaud; V Gratio; M Laburthe
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

View more
  5 in total

1.  Etiologic Role of Kinases in the Progression of Human Cancers and Its Targeting Strategies.

Authors:  Sanjoy Das; Bireswar Bhattacharya; Biplajit Das; Bibek Sinha; Taison Jamatia; Kishan Paul
Journal:  Indian J Surg Oncol       Date:  2019-08-19

2.  Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity.

Authors:  Qi-Yin Chen; Yanxia Liu; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2011-08-31       Impact factor: 4.345

3.  CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways.

Authors:  Bisweswar Nandi; Jonathan Pastrana Del Valle; Mehmet K Samur; Allison J Gibbons; Rao H Prabhala; Nikhil C Munshi; Jason S Gold
Journal:  Oncotarget       Date:  2021-11-23

4.  Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.

Authors:  Qi-Yin Chen; Yanxia Liu; Weijing Cai; Hendrik Luesch
Journal:  J Med Chem       Date:  2014-03-24       Impact factor: 7.446

5.  Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells.

Authors:  Sareh Kamran; Ajantha Sinniah; Zamri Chik; Mohammed Abdullah Alshawsh
Journal:  Biomedicines       Date:  2022-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.